Interaction of CD47 with the signal regulatory protein-alpha (SIRPα) receptor expressed on many myeloid derived cell lineages activates molecular pathways effectively inhibiting an anti-tumor function of innate immunity (30). The gene discussed is SIRPA; the disease is neoplasm.